scholarly journals On the diagnosis of chronic cholecystitis and the clinical significance of some methods for the study of bile

2021 ◽  
Vol 43 (3) ◽  
pp. 17-19
Author(s):  
A. L. Landa ◽  
A. A. Krylov ◽  
G. A. Trofimov A. Trofimov

The problems of liver and biliary tract pathology occupy a prominent place among the problems attracting special attention of clinicians.

2008 ◽  
Vol 130 (5) ◽  
pp. 780-786 ◽  
Author(s):  
Eva Karamitopoulou ◽  
Luigi Tornillo ◽  
Inti Zlobec ◽  
Lukas Cioccari ◽  
Vincenza Carafa ◽  
...  

Radiographics ◽  
1991 ◽  
Vol 11 (3) ◽  
pp. 441-456 ◽  
Author(s):  
G G Ghahremani ◽  
A R Crampton ◽  
J R Bernstein ◽  
J A Caprini

2013 ◽  
Vol 2013 ◽  
pp. 1-15 ◽  
Author(s):  
Jose Behar

The biliary tract collects, stores, concentrates, and delivers bile secreted by the liver. Its motility is controlled by neurohormonal mechanisms with the vagus and splanchnic nerves and the hormone cholecystokinin playing key roles. These neurohormonal mechanisms integrate the motility of the gallbladder and sphincter of Oddi (SO) with the gastrointestinal tract in the fasting and digestive phases. During fasting most of the hepatic bile is diverted toward the gallbladder by the resistance of the SO. The gallbladder allows the gradual entry of bile relaxing by passive and active mechanisms. During the digestive phase the gallbladder contracts, and the SO relaxes allowing bile to be released into the duodenum for the digestion and absorption of fats. Pathological processes manifested by recurrent episodes of upper abdominal pain affect both the gallbladder and SO. The gallbladder motility and cytoprotective functions are impaired by lithogenic hepatic bile with excess cholesterol allowing the hydrophobic bile salts to induce chronic cholecystitis. Laparoscopic cholecystectomy is the standard treatment. Three types of SO dyskinesia also cause biliary pain. Their pathophysiology is not completely known. The pain of types I and II usually respond to sphincterotomy, but the pain due to type III usually does not.


2021 ◽  
pp. 122-134
Author(s):  
I. V. Maev ◽  
D. S. Bordin ◽  
T. A. Ilchishina ◽  
Yu. A. Kucheryavyy

In  the  structure of  gastrointestinal diseases, the  pathology of  the  hepatobiliary system currently ranks second in  frequency of occurrence. The stages of diseases of the biliary system can be combined into the so-called “biliary continuum”, when one patient has a consistent development of pathogenetically related diseases of the biliary tract. The progressive course of functional motility disorders of the biliary tract gradually leads to the development of organic pathology, including chronic cholecystitis, the subsequent development of gallstone disease and possible postcholecystectomy complications. Among the diseases of the biliary system, one of the most frequently used diagnoses is chronic cholecystitis. The development of chronic cholecystitis is associated with repeated attacks of acute inflammation or prolonged irritation of large gallstones. The clinical aspects of chronic cholecystitis and other pathologies included in the the «biliary continuum» largely depends on concomitant dyskinesia. There are several directions for the treatment of pathologies of the biliary system: diet therapy, medication, endoscopic and surgical treatment. According to the latest guidelines, the most important direction in modern therapy of diseases of the biliary system is the restoration of the motility of the biliary tract and the normalization of the physicochemical properties of bile. The central place in the treatment of diseases of the “biliary continuum” is given to antispasmodic drugs. The administration of antispasmodics is recommended in order to relieve biliary pain and dyspeptic symptoms caused by spasm of smooth muscles, as well as to control the inflammatory process due to a decrease in the release of pro-inflammatory substances. This article describes in detail the importance of the recovery of the biliary tract motor activity and the improvement of the physico-chemical properties of bile acids.


1996 ◽  
Vol 40 (3) ◽  
pp. 787-791 ◽  
Author(s):  
C E Edmiston ◽  
E C Suarez ◽  
A P Walker ◽  
M P Demeure ◽  
C T Frantzides ◽  
...  

Forty patients with chronic cholecystitis or cholelithiasis were prospectively randomized for therapy with either ciprofloxacin or fleroxacin to study the penetration of these two agents into gallbladder tissue, plasma, and bile. Patients received a 3-day course of ciprofloxacin (500 mg twice a day) or fleroxacin (400 mg once daily) and were subdivided into four groups reflecting intraoperative sample collection at 4, 7, 14, and 25 to 26 h following the last quinolone dose. Mean concentrations in plasma for ciprofloxacin and fleroxacin at 4 and 25 to 26 h postdose were 2.5 and 10 micrograms/ml and 0.3 and 1.8 micrograms/ml, respectively. The concentrations of ciprofloxacin and fleroxacin in bile and gallbladder wall tissue at 25 to 26 h postdose were 4.5 and 8.6 micrograms/ml and 1.2 and 4.4 micrograms/ml, respectively. Both agents demonstrate rapid tissue penetration with persistence at levels appropriate for treatment of biliary pathogens.


2017 ◽  
Vol 225 (4) ◽  
pp. e128
Author(s):  
Tokuji Ito ◽  
Shogo Tanaka ◽  
Shigekazu Takemura ◽  
Genya Hamano ◽  
Yukiko Kurashima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document